Many studies have confirmed the dysregulation of serine uptake or biosynthesis in tumour cells, as well as abnormal PHGDH expression, in different tumours, including lymphoma, multiple myeloma, glioma, hepatocellular carcinoma, melanoma, colon cancer, breast cancer, and others 32-38. The gene discussed is PHGDH; the disease is breast carcinoma.